© 2022 American College of Medical Genetics and Genomics. All rights reserved.
Genetics101 for Healthcare Providers
Date of Release: 2/1/2022
Expiration Date: 2/1/2025
Credits offered: .5 per module
Estimate time of completion: 5 hours
Course/Module must be completed by the expiration date
This course is supported by an independent medical education grant from Illumina, Inc.
Target Audience:
This course is primarily for the non-geneticist healthcare professional.
Accreditation
The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement: The American College of Medical Genetics and Genomics designates this online enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accredited Continuing Education Financial Disclosure
The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.
ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
ACMG Education Policies
Please review the policies below regarding the ACMG Education program
• Financial Disclosures and Mitigation Procedure
• ACMG Content Validation Policy
• ACMG Content Branding Policy
Financial Support Disclosure Statement: The following course director, program planning committee members, speakers, and staff for this activity, have no financial relationships with ineligible companies relevant to the content of this course.
Salman Kirmani MBBS, FABP, FACMG
The Aga Khan University
Nothing to disclose
Content Contributors
Salman Kirmani MBBS, FABP, FACMG
Associate Professor & Chair,
Division of Women & Child Health, Aga Khan University, Karachi
Consultant Pediatric Endocrinologist & Medical Geneticist
Dr. Salman Kirmani is a Medical Geneticist & Pediatric Endocrinologist associated with Aga Khan University as an Associate Professor of Paediatrics and Medicine, Chair (Division of Women & Child Health), and Interim Chair (Department of Paediatrics & Child Health). Dr. Kirmani did his MBBS (MD) from Dow Medical College, Karachi followed by Residency & Fellowships from Mayo School of Graduate Medical Education, Mayo Clinic, Rochester, MN. Dr. Kirmani is certified by the American Board of Medical Genetics (Clinical Genetics), and the American Board of Pediatrics (General Pediatrics & Pediatric Endocrinology). He was on faculty at the Mayo Clinic till he returned to Pakistan to join the Aga Khan University in 2014.
Dr. Kirmani has a rich and diverse experience in education, clinical service, research and advocacy. He has authored over 50 peer-reviewed articles and two book chapters, and is part of numerous well-funded research studies in his field. He has won a number of teaching awards, and has successfully trained Pakistan's first genetic counselor, Ms. Fizza Akbar. Together with his multidisciplinary team at AKU, he has developed a Pediatric Genetics Clinic, Hereditary Cancer Clinic, Adult Neurogenetics Clinic, and a Perinatal Genetics Clinic, the first of their kind in Pakistan. He is on the board of a number of parent support groups for rare genetic disorders, including the Karachi Down Syndrome Program, and DEBRA Pakistan. He continually strives to make the advances in Genetics and Genomics accessible to people in Pakistan, and create a team of healthcare professionals who may deliver Precision Medicine solutions to populations with the highest burden of genetic disorders.
Peer Review
In December of 2021, this continuing medical education online enduring activity was reviewed by Drs. Shweta Dhar and Fuki Hisama. To ensure the continued scientific relevance of this enduring material, its content will be reviewed again prior to the expiry date.
Disclaimer
ACMG educational programs are designed primarily as an educational tool for health care providers who wish to increase their understanding of the application of genomic technologies to patient care. The ACMG does not endorse or recommend the use of this educational program to make patient diagnoses, particular by individuals not trained in medical genetics. Adherence to the information provided in these programs does not necessarily ensure a successful diagnostic outcome. The program should not be considered inclusive of all proper procedures and or exclusive of other procedures and that are reasonably directed at obtaining the same results. In determining the propriety of any specific procedure or, a healthcare provider should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen.
Questions regarding CE credit should be directed to education@acmg.net